Nathalie Chami,Ming-Huei Chen,Andrew J. Slater,John D. Eicher,Εvangelos Εvangelou,Salman M. Tajuddin,Latisha Love‐Gregory,Tim Kacprowski,Ursula M. Schick,Akihiro Nomura,Ayush Giri,Samuel Lessard,Estonia Biobank Research Team Finngen,Claudia Schurmann,Nathan Pankratz,Lisa R. Yanek,Ani Manichaikul,Raha Pazoki,Evelin Mihailov,W. David Hill,Laura M. Raffield,Amber Burt,Traci M. Bartz,Diane M. Becker,Lewis C. Becker,Eric Boerwinkle,Jette Bork‐Jensen,Erwin P. Böttinger,Michelle L. O’Donoghue,David R. Crosslin,Simon de Denus,Marie‐Pierre Dubé,Paul Elliott,Gunnar Engström,Michele K. Evans,James S. Floyd,Myriam Fornage,Gaohong He,Andreas Greinacher,Vilmundur Gudnason,Torben Hansen,Tamara B. Harris,Caroline Hayward,Jussi Hernesniemi,Heather M. Highland,Joel N. Hirschhorn,Albert Hofman,Marguerite R. Irvin,Mika Kähönen,Ethan M. Lange,Lenore J. Launer,Terho Lehtimäki,Jin Li,David C. Liewald,Allan Linneberg,Yongmei Liu,Yingchang Lu,Leo-Pekka Lyytikäinen,Reedik Mägi,Rasika A. Mathias,Olle Melander,Andres Metspalu,Nina Mononen,Mike A. Nalls,Deborah A. Nickerson,Kjell Nikus,Chris O’Donnell,Marju Orho‐Melander,Oluf Pedersen,Astrid Petersmann,Linda M. Polfus,Bruce M. Psaty,Olli Raitakari,Emma Raitoharju,Melissa A. Richard,Kenneth Rice,Fernando Rivadeneira,Jerome I. Rotter,Frank L. Schmidt,Albert V. Smith,John M. Starr,Kent D. Taylor,Alexander Teumer,Betina H. Thuesen,Eric S. Torstenson,Russell P. Tracy,Ioanna Tzoulaki,Neil A. Zakai,Caterina Vacchi‐Suzzi,Cornelia M. van Duijn,Frank J.A. van Rooij,Mary Cushman,Ian J. Deary,Digna R. Velez Edwards,Anne-Claire Vergnaud,Lars Wallentin,Dawn Waterworth,Harvey D. White,James Wilson,Alan B. Zonderman,Sekar Kathiresan,Niels Grarup,Tõnu Esko,Ruth J. F. Loos,Leslie A. Lange,Nauder Faraday,Nada A. Abumrad,Todd L. Edwards,Santhi K. Ganesh,Paul L. Auer,Andrew D. Johnson,Alexander P. Reiner,Guillaume Lettre

Abstract:Red blood cell (RBC) traits are important heritable clinical biomarkers and modifiers of disease severity. To identify coding genetic variants associated with these traits, we conducted meta-analyses of seven RBC phenotypes in 130,273 multi-ethnic individuals from studies genotyped on an exome array. After conditional analyses and replication in 27,480 independent individuals, we identified 16 new RBC variants. We found low-frequency missense variants in MAP1A (rs55707100, minor allele frequency [MAF] = 3.3%, p = 2 × 10−10 for hemoglobin [HGB]) and HNF4A (rs1800961, MAF = 2.4%, p < 3 × 10−8 for hematocrit [HCT] and HGB). In African Americans, we identified a nonsense variant in CD36 associated with higher RBC distribution width (rs3211938, MAF = 8.7%, p = 7 × 10−11) and showed that it is associated with lower CD36 expression and strong allelic imbalance in ex vivo differentiated human erythroblasts. We also identified a rare missense variant in ALAS2 (rs201062903, MAF = 0.2%) associated with lower mean corpuscular volume and mean corpuscular hemoglobin (p < 8 × 10−9). Mendelian mutations in ALAS2 are a cause of sideroblastic anemia and erythropoietic protoporphyria. Gene-based testing highlighted three rare missense variants in PKLR, a gene mutated in Mendelian non-spherocytic hemolytic anemia, associated with HGB and HCT (SKAT p < 8 × 10−7). These rare, low-frequency, and common RBC variants showed pleiotropy, being also associated with platelet, white blood cell, and lipid traits. Our association results and functional annotation suggest the involvement of new genes in human erythropoiesis. We also confirm that rare and low-frequency variants play a role in the architecture of complex human traits, although their phenotypic effect is generally smaller than originally anticipated. Red blood cell (RBC) traits are important heritable clinical biomarkers and modifiers of disease severity. To identify coding genetic variants associated with these traits, we conducted meta-analyses of seven RBC phenotypes in 130,273 multi-ethnic individuals from studies genotyped on an exome array. After conditional analyses and replication in 27,480 independent individuals, we identified 16 new RBC variants. We found low-frequency missense variants in MAP1A (rs55707100, minor allele frequency [MAF] = 3.3%, p = 2 × 10−10 for hemoglobin [HGB]) and HNF4A (rs1800961, MAF = 2.4%, p < 3 × 10−8 for hematocrit [HCT] and HGB). In African Americans, we identified a nonsense variant in CD36 associated with higher RBC distribution width (rs3211938, MAF = 8.7%, p = 7 × 10−11) and showed that it is associated with lower CD36 expression and strong allelic imbalance in ex vivo differentiated human erythroblasts. We also identified a rare missense variant in ALAS2 (rs201062903, MAF = 0.2%) associated with lower mean corpuscular volume and mean corpuscular hemoglobin (p < 8 × 10−9). Mendelian mutations in ALAS2 are a cause of sideroblastic anemia and erythropoietic protoporphyria. Gene-based testing highlighted three rare missense variants in PKLR, a gene mutated in Mendelian non-spherocytic hemolytic anemia, associated with HGB and HCT (SKAT p < 8 × 10−7). These rare, low-frequency, and common RBC variants showed pleiotropy, being also associated with platelet, white blood cell, and lipid traits. Our association results and functional annotation suggest the involvement of new genes in human erythropoiesis. We also confirm that rare and low-frequency variants play a role in the architecture of complex human traits, although their phenotypic effect is generally smaller than originally anticipated.

A genome-wide association study of blood cell morphology identifies cellular proteins implicated in disease aetiology

Genetic Analyses of Blood Cell Structure for Biological and Pharmacological Inference

The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease

The Polygenic and Monogenic Basis of Blood Traits and Diseases

Large-Scale Exome-wide Association Analysis Identifies Loci for White Blood Cell Traits and Pleiotropy with Immune-Mediated Diseases

Whole-genome Sequencing in Diverse Subjects Identifies Genetic Correlates of Leukocyte Traits: the NHLBI TOPMed Program

Transcriptome-Wide Association Study of Blood Cell Traits in African Ancestry and Hispanic/Latino Populations

Multi-ethnic Genome-Wide Association Analyses of White Blood Cell and Platelet Traits in the Population Architecture Using Genomics and Epidemiology (PAGE) Study

A genome- and phenome-wide association study to identify genetic variants influencing platelet count and volume and their pleiotropic effects

Trans-ethnic and Ancestry-Specific Blood-Cell Genetics in 746,667 Individuals from 5 Global Populations

Whole genome sequencing identifies structural variants contributing to hematologic traits in the NHLBI TOPMed program

Whole-genome Sequencing Association Analysis of Quantitative Red Blood Cell Phenotypes: the NHLBI TOPMed Program.

Exome Genotyping Identifies Pleiotropic Variants Associated with Red Blood Cell Traits

Whole-Exome Sequencing Identifies Loci Associated with Blood Cell Traits and Reveals a Role for Alternative GFI1B Splice Variants in Human Hematopoiesis

Seventy-five genetic loci influencing the human red blood cell

Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits

Whole Genome Sequence Analysis of Platelet Traits in the NHLBI Trans-Omics for Precision Medicine (topmed) Initiative.

A Meta-Analysis of Immune-Cell Fractions at High Resolution Reveals Novel Associations with Common Phenotypes and Health Outcomes

Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease

Genetic Drivers of Epigenetic and Transcriptional Variation in Human Immune Cells

Interrogation of human hematopoiesis at single-cell and single-variant resolution